Stifel Initiates Coverage On Trex Bio with Buy Rating, Announces Price Target of $39
Stifel analyst Alex Thompson initiates coverage on Trex Bio (NASDAQ:TRXB) with a Buy rating and announces Price Target of $39.
Share
Why It Matters
A professional stock watcher started following Trex Bio and thinks it looks good. When experts begin watching a company, it can mean they see exciting things ahead.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.